Lifastuzumab vedotin
Lifastuzumab vedotin (LIFA, DNIB0600A, RG-7599) is an antibody-drug conjugate (ADC) composed of a humanized anti-NaPi2b monoclonal antibody and an anti-mitotic cytotoxic agent, monomethyl auristatin E (MMAE) . Lifastuzumab vedotin is used in the treatment of platinum-resistant ovarian cancer.
Trivial name | LIFA, DNIB0600A, RG-7599 |
Catalog Number | D4010 |
CAS# | 1401812-88-1 |
Size | 1mg*5 |
Supplier Page | http://www.selleckchem.com/products/lifastuzumab-vedotin.html |